Trinity Biotech PLC
TRIB1.190USD
-0.020-1.65%
收盤 09/19, 16:00（美東）報價延遲15分鐘
9.87M總市值
虧損本益比TTM
關於 Trinity Biotech PLC 公司
Trinity Biotech plc 是一家位於愛爾蘭的商業階段生物技術公司。該公司專注於人體診斷和糖尿病管理解決方案，包括可穿戴生物傳感器。該公司開發、收購、製造和銷售診斷系統，包括試劑和儀器，用於診斷市場的即時診斷和臨牀實驗室部分，並已進入可穿戴生物傳感器行業。該公司打算開發一系列生物傳感器設備和相關服務，從連續血糖監測產品開始。其產品用於檢測傳染病和量化血清、血漿和全血中的糖化血紅蛋白水平和其他化學參數。該公司還通過 EpiCapture Limited 開發了一種用於監測侵襲性前列腺癌風險的非侵入性測試。該公司在美國直接銷售其產品，並通過國際分銷商網絡銷售。
公司簡介
公司代碼TRIB
公司名稱Trinity Biotech PLC
上市日期Oct 21, 1992
CEOMr. John Gillard
員工數量- -
證券類型Depository Receipt
年結日Oct 21
公司地址Ida Business Park, Bray, Co Wicklow
城市DUBLIN
上市交易所NASDAQ Global Select Consolidated
國家Ireland
郵編18
電話01135312955111
網址https://www.trinitybiotech.com/
公司代碼TRIB
上市日期Oct 21, 1992
CEOMr. John Gillard
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Ms. Susan O'Connor
Ms. Susan O'Connor
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Dr. Matthew Wictome
Dr. Matthew Wictome
Vice President - Quality and Regulatory Affairs
Vice President - Quality and Regulatory Affairs
--
--
Mr. Eric Ribner
Mr. Eric Ribner
Investors Relations
Investors Relations
--
--
Mr. Ronan O'caoimh
Mr. Ronan O'caoimh
Founder, Executive Director
Founder, Executive Director
--
--
Mr. John Gillard
Mr. John Gillard
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
--
--
Ms. Eibhlin Kelly
Ms. Eibhlin Kelly
Chief Information Officer
Chief Information Officer
--
--
Dr. Gary Keating, Ph.D.
Dr. Gary Keating, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Colm Molloy
Mr. Colm Molloy
Group Director of Human Resources and Culture
Group Director of Human Resources and Culture
--
--
Dr. James (Jim) Walsh, Ph.D.
Dr. James (Jim) Walsh, Ph.D.
Executive Director - Business Development
Executive Director - Business Development
--
--
Mr. Andrew Omidvar, Ph.D.
Mr. Andrew Omidvar, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Ms. Susan O'Connor
Ms. Susan O'Connor
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Dr. Matthew Wictome
Dr. Matthew Wictome
Vice President - Quality and Regulatory Affairs
Vice President - Quality and Regulatory Affairs
--
--
Mr. Eric Ribner
Mr. Eric Ribner
Investors Relations
Investors Relations
--
--
Mr. Ronan O'caoimh
Mr. Ronan O'caoimh
Founder, Executive Director
Founder, Executive Director
--
--
Mr. John Gillard
Mr. John Gillard
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
--
--
Ms. Eibhlin Kelly
Ms. Eibhlin Kelly
Chief Information Officer
Chief Information Officer
--
--
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Clinical Laboratory
42.29M
74.41%
Point of care
9.09M
16.00%
Laboratory services
5.45M
9.59%
地區USD
名稱
營收
佔比
Americas
44.98M
79.15%
Ireland
11.85M
20.85%
Eliminations
0.00
0.00%
業務
地區
業務USD
名稱
營收
佔比
Clinical Laboratory
42.29M
74.41%
Point of care
9.09M
16.00%
Laboratory services
5.45M
9.59%
股東統計
更新時間: 8月23日 週六
更新時間: 8月23日 週六
持股股東
股東類型
持股股東
持股股東
佔比
MiCo IVD Holdings, LLC
2.40%
Perceptive Advisors LLC
1.92%
Hunter Associates Investment Management LLC
0.47%
Whitefort Capital Management, LP
0.09%
Renaissance Technologies LLC
0.06%
其他
95.06%
持股股東
持股股東
佔比
MiCo IVD Holdings, LLC
2.40%
Perceptive Advisors LLC
1.92%
Hunter Associates Investment Management LLC
0.47%
Whitefort Capital Management, LP
0.09%
Renaissance Technologies LLC
0.06%
其他
95.06%
股東類型
持股股東
佔比
Corporation
2.40%
Private Equity
1.92%
Investment Advisor
0.59%
Hedge Fund
0.17%
Investment Advisor/Hedge Fund
0.05%
Research Firm
0.03%
Venture Capital
0.03%
其他
94.81%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
50
3.17M
16.99%
-2.03M
2025Q1
53
3.13M
16.78%
-2.10M
2024Q4
50
4.89M
27.09%
-355.77K
2024Q3
47
4.97M
53.06%
-277.40K
2024Q2
45
4.94M
57.57%
-285.83K
2024Q1
44
5.20M
60.32%
-76.86K
2023Q4
40
3.94M
51.41%
+207.86K
2023Q3
42
3.97M
51.90%
+190.94K
2023Q2
47
3.98M
52.08%
+190.03K
2023Q1
47
3.51M
70.22%
+1.91M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
MiCo IVD Holdings, LLC
2.24M
12.01%
--
--
Dec 17, 2024
Hunter Associates Investment Management LLC
375.11K
2.01%
-3.48K
-0.92%
Mar 31, 2025
Whitefort Capital Management, LP
81.90K
0.44%
--
--
Mar 31, 2025
Renaissance Technologies LLC
76.67K
0.41%
-112.39K
-59.45%
Mar 31, 2025
Highbridge Capital Management, LLC
33.75K
0.18%
+33.75K
--
Mar 31, 2024
Moss Adams Wealth Advisors LLC
25.67K
0.14%
--
--
Mar 31, 2025
Raymond James & Associates, Inc.
25.35K
0.14%
--
--
Mar 31, 2025
Cambridge Investment Research Advisors, Inc.
22.28K
0.12%
--
--
Mar 31, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Feb 13, 2024
Merger
5→1
Feb 13, 2024
Merger
5→1
Feb 13, 2024
Merger
5→1
Feb 13, 2024
Merger
5→1
公告日期
類型
比率
Feb 13, 2024
Merger
5→1
Feb 13, 2024
Merger
5→1
Feb 13, 2024
Merger
5→1
Feb 13, 2024
Merger
5→1
